The effect of autologous peripheral blood cells transplantation along with platelet rich plasma in the treatment of patients with vesicoureteral reflux

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170417033489N4

Enrollment

Registered

2020-04-28

Start date

2011-10-22

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vesicoureteral reflux. Vesicoureteral-reflux

Interventions

This study aimed to evaluate the therapeutic efficacy of endoscopic subureteric injection of autologous peripheral blood cells along with platelet-rich plasma. Each injection contained whole blood cel

Eligibility

Sex/Gender

All

Age

15 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patient with re flux grade 2, 3 or 4 grade No surgical treatment has been performed so far

Exclusion criteria

Exclusion criteria: The patient is in the acute phase of urinary tract infection Patient with renal failure due to re flux Patient with grade 1 or 5 re flux

Design outcomes

Primary

Measure	Time frame
Reflux Grade. Timepoint: Determination of urinary reflux grade at baseline, three and six months after intervention. Method of measurement: Ultrasound, Cystography, U/A, U/C.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaliheh Keshvari Shirvan

Mashhad University of Medical Sciences

keshvarim@mums.ac.ir+98 51 3858 3885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026